Tuberculosis treatment outcome: The case of women in Ethiopia and China, ten-years retrospective cohort study


Autoři: Xiao Ma aff001;  Gebremeskel Mirutse aff002;  Alemayehu Bayray aff002;  Mingwang Fang aff003
Působiště autorů: Department of Health-Related Social and Behavioral Science, West China School of Public Health, Sichuan University, Chengdu, China aff001;  Schools of Public Health, College of Health Science, Mekelle University, Tigray, Ethiopia aff002;  West China Hospital, Sichuan University, Chengdu, China aff003
Vyšlo v časopise: PLoS ONE 14(11)
Kategorie: Research Article
doi: 10.1371/journal.pone.0219230

Souhrn

Background

Every year tuberculosis kills above half million women all over the world. Nonetheless, the factor affecting TB treatment outcome of women was less frequently studied and compared among countries. Hence, this study was aimed to measure and compare outcome of treatment and the death size of these two countries.

Method

Socio demographic and clinical data of women treated for all form of tuberculosis in the past ten years 2007–2016 were collected from total of eight hospitals and six treatment centers of Tigray and Zigong respectively. Then, we measured the magnitude of TB, level of treatment success and identify factors associated with the unsuccessful TB outcome.

Result

In the past ten years, a total of 5603(41.5%) and 4527 (24.5%) tuberculosis cases were observed in Tigray and Zigong respectively. Of those with treatment outcome record a total of 2602(92%) in Tigray and 3916(96.7%) in Zigong were successfully treated. Total of 170 (6%) cases in Tigray and 36(0.8%) cases in Zigong were dead. In Tigray, retreatment cases (aOR, 0.29; 95% CI: 0.16–0.53) and MDR-TB cases (aOR, 0.31; 95% CI: 0.003, 0.27) were less likely to show treatment success. However,, HIV co-infected TB cases (aOR, 3.58; 95% CI: 2.47, 5.18) were more likely to show treatment success compared with unknown HIV status. In Zigong, women with MDR TB (aOR, 0.90; 95%CI: 0.24, 0.34) were less likely to show treatment success and women in the age category of 15–49 (aOR, 1.55; 95% CI: 1.08, 2.206) were more likely to show treatment success.

Conclusion

Big number of tuberculosis cases and death were observed in Tigray comparing with Zigong. Hence, a relevant measure should be considered to improve treatment outcome of women in Tigray regional state.

Klíčová slova:

Drug therapy – Ethiopia – China – Multi-drug-resistant tuberculosis – Tuberculosis – Tuberculosis diagnosis and management – Tuberculosis drug discovery


Zdroje

1. Philippe G, C.S., Katherine F, Mario R, Global Epidemiology of Tuberculosis. Cold Spring Harbor Laboratory Press, 2014: p. 18.

2. WHO. Global Tuberculosis Report. [Internet] 2015 [cited 2017 2 16]; Available from: https://www.who.int/tb/publications/global_report.

3. WHO. Global Tuberculosis Report [Internet] 2013 [cited 2017 1 20]; Available from: https://www.who.int/tb/publications/global_report.

4. TBalert. For a Future Without Tuberculosis. [Internet] [cited 2017 5 12]; Available from: https://www.tbalert.org/.

5. Haileyesus G, D.S., Charalambos S, Malgorzata G, Mario R, Prevention, Diagnosis, and Treatment of Tuberculosis in Children and Mothers: Evidence for Action for Maternal, Neonatal, and Child Health Services. Journal of Infectious Diseases., 2012. 205: p. 12.

6. WHO., Trade, foreign policy, diplomacy and health 2017. 2017.

7. FDREMOH, E., First National population based tuberculosis prevalence survey 2011.

8. Li Yuan H.Z., Zhou Changming, Jiang Weili, Zhao Qi Biao Xu, Better Care Provided to Patients with Tuberculosis at County Designated TB Hospitals (CTD) Compared to Non-CTDs in Rural China. BMC infectious diseases, 2017. 17(71): p. 7.

9. Guanyang Z, R.K., John W, Barriers to Hospital and Tuberculosis Programme Collaboration in China: Context Matters. Global Health Action 2015. 8(27067): p. 9.

10. WHO. Global Tuberculosis Report [Internet] 2016 [cited 2017 3 19]; Available from: https://www.who.int/tb/publications/global_report.

11. Ying Tang M.Z., Wang Yunxia, Gong Yanhong, Yin Xiaoxv, Zhao Angui, , Non-Adherence to Anti-Tuberculosis Treatment among Internal Migrants with Pulmonary Tuberculosis in Shenzhen, China: a Cross-sectional study. BMC public health 2015. 15(474): p. 6.

12. WHO. Global Tuberculosis Control [Internet] 2010 [cited 2017 1 26]; Available from: https://www.who.int/tb/publications/global_report.

13. Berhe G, E.F., Aseffa A, Treatment Outcome of Smear-Positive Pulmonary Tuberculosis Patients in Tigray Region, Northern Ethiopia. BMC Public Health, 2012. 12(537).

14. TRHB, Tigray Regional Health Bureau First Draft 2008 EFY Annual Profile, 2016.

15. Hai-Can Liu J.-P.D., Dong Hai-Yan, Xiao Ti-Quan, Zhao Xiu-Qin, Zhang Zheng-Dong, Jiang Yi, Liu Zhi-Guang, Li Qun, Wan Kang-Lin, Molecular Typing Characteristic and Drug Susceptibility Analysis of Mycobacterium tuberculosis Isolates from Zigong, China. BioMed Research International, 2016. 2016(2016): p. 7

16. CSP. New Statistical Year books 2015. Beijing: China Statistics Press. [Internet] 2016 [cited 2018 3 27]; Available from: http://www.stats.gov.cn/tjsj/ndsj/2015/indexch.htm

17. Senedu B, G.S., Yimer G Tuberculosis Case Notification and Treatment Outcomes in West Gojjam Zone, Northwest Ethiopia: A Five-Year Retrospective Study. Journal of Tuberculosis Research,, 2016. 4: p. 23–33.

18. CSA. Population Projections for Ethiopia 2007–2037. [Internet] 2013 [cited 2017 5 11]; Available from: www.csa.gov.et/census-report/population-projections/category/368-population-projection-2007-2037.

19. FMOH, E. First Ethiopian National Population Based Tuberculosis Prevalence Survey 2011. [Internet ] [cited 2017 1024]; Available from: https://www.ephi.gov.et/images/downloads/Tuberculosis

20. Dangisso MH, D.D., Lindtjørn B Trends of Tuberculosis Case Notification and Treatment Outcomes in the Sidama Zone, Southern Ethiopia: Ten-Year Retrospective Trend Analysis in Urban-Rural Settings. PLoS ONE, 2014. 9(12): p. 18.

21. FMOH. Tuberculosis, Leprosy and TB/HIV Prevention and Control Programme [Internet] [cited 2018 2 14]; Available from: https://www.who.int/hiv/pub/guidelines/ethiopia_tb.pdf.

22. WHO. Treatment of Tuberculosis Guidlines for National Programmes. [Internet] [cited 2017 1 13]; Available from: https://apps.who.int/iris/bitstream/handle/10665/67890/WHO_CDS_TB.

23. Hou W-L, F.-J.S., Zhang N-X Implementation and Community Involvement in DOTS Strategy: A Systematic Review of Studies in China. The International Journal of Tuberculosis and Lung Disease, 2012. 16(11): p. 9.

24. ADIS, T.G.C.o.W.a. Tackling TB and HIV in Women: An Urgent Agenda [Internet] 2010 [cited 2018 2 16]; Available from: www.womenandaids.net.

25. Keertan D, T.G., Neel R Global Control of Tuberculosis: From Extensively Drug-Resistant to Untreatable Tuberculosis. Lancet Respir Med., 2014. 2(4): p. 39.

26. Marais J.N.S.A.B.J., Tuberculosis among Older Adults–Time to Take Notice. International Journal of Infectious Diseases, 2014. 32(2015): p. 3.

27. Saba A, G.M., Ashenafi S, Magnitude of Chronic Energy Deficiency and its Associated Factors among Women of Reproductive Age in the Kunama Population, Tigray, Ethiopia, in 2014. BMC Nutrtion 2015. 1(12): p. 9.

28. Krishna Bihari Gupta R.G., Atreja Atulya, Tuberculosis and Nutrition. Lung India 2009. 26(1): p. 8.

29. TRHB, Tigray Regional Health Bureau 2015 Annual Profile 2015.

30. Kanabus, A. Information about Tuberculosis. [Internet] GHE 2018 [cited 2018 2 11]; Available from: www.tbfacts.org.

31. Solomon Y, C.H.H., Tilahun Y Health Care Seeking Among Pulmonary Tuberculosis suspects and Patients in Rural Ethiopia: a Community-Based Study. BMC Public Health, 2009. 9 (454).

32. Danielle C, H.A., Srinath S, Quality of Ttuberculosis Care in High Burden Countries: the Urgent Need to Address Gaps in the Care Cascade. International Journal of Infectious Diseases, 2016. 56 (2017): p. 6.

33. Solomon A, T.R., Ribka F, Tadesse A, Outcomes of TB treatment in HIV Co-infected TB patients in Ethiopia: a Cross-sectional analytic study. BMC Infectious Diseases 2016. 16(640): p. 9.

34. Jin X.L.Y.L.Z.C.G.S.G.L., Treatment outcomes of pulmonary tuberculosis in the past decade in the mainland of China: a Meta-analysis. Springer Berlin Heidelberg, 2013. 7(3): p. 13.

35. Wang X, C.J., Wang D, Wang Q, Liang H, Ma A, Schouten EG, Kok FJ, Registration and Management of Community Patients with Tuberculosis in North-West China. Elsevier public health, 2015. 129(12): p. 6.

36. Nabukenya, Tuberculosis Retreatment ‘Others’ in Comparison with Classical Retreatment Cases; A Retrospective Cohort Review. BMC Public Health, 2015. 15(840): p. 8.

37. Sangita VP, K.N., Alpesh Patel B.,, Treatment outcome among cases of multidrug-resistant tuberculosis (MDR TB) in Western India: A prospective study. Journal of Infection and public health, 2015. 2016(9): p. 7.

38. Ynni S, D.H., Hassan V, Adrian S, Comparison of Characteristics and Mortality in Multidrug Resistant (MDR) and Non-MDR Tuberculosis Patients in China. BMC Public Health, 2015. 15(1027): p. 8.

39. Avranil G, U.C., Correlates of Treatment Outcomes and Drug Resistance among Pulmonary Tuberculosis Patients Attending Tertiary Care Hospitals of Kolkata, India. PLOS ONE www.plosone.org, 2014. 9(10): p. 12.


Článek vyšel v časopise

PLOS One


2019 Číslo 11